Drawing for RYMTACLI

USPTO serial 88048891

RYMTACLI

Reviewed by CopyMark Law Group

Reg. 6805738Status 700Registered
Filing date
Status date
Registration date
Aug 2, 2022
Examiner
LIU, PHILIP HUAI-EN
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with RYMTACLI?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Cynthia Smuzynska

Cynthia Smuzynska Gilead Sciences, Inc.333 Lakeside DriveFoster City, CA 94404United States

Goods and services

ClassDescriptionStatusFirst use
005Antiviral pharmaceutical preparations; anti-infective pharmaceutical preparations; anti-fibrotic pharmaceutical preparations; pharmaceutical preparations for treatment and prevention of HIV infection; pharmaceutical preparations for the treatment of liver diseases and disorders; pharmaceutical preparations for the treatment of hematological diseases and disorders; pharmaceutical preparations for the treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of inflammatory diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of respiratory and pulmonary diseases and disorders; pharmaceutical preparations for the treatment of kidney and nephropathic diseases and disorders; pharmaceutical preparations for the treatment of arthritisACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 9, 2026TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jul 9, 2026ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 9, 2026REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jul 9, 2026CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jul 9, 2026COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Aug 2, 2022NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Aug 2, 2022R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 27, 2022DP1B1(B) BASIS DELETED; PROCEED TO REGISTRATION—
Jun 27, 2022AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
May 3, 2022IUCNNOTICE OF ALLOWANCE CANCELLED—
May 3, 2022D1BRTEAS DELETE 1(B) BASIS RECEIVED—
Sep 18, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 16, 2021EX4GSOU EXTENSION 4 GRANTED—
Sep 16, 2021EXT4SOU EXTENSION 4 FILED—
Sep 16, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 2, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 31, 2021EX3GSOU EXTENSION 3 GRANTED—
Mar 31, 2021EXT3SOU EXTENSION 3 FILED—
Mar 31, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 24, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 22, 2020EX2GSOU EXTENSION 2 GRANTED—
Sep 22, 2020EXT2SOU EXTENSION 2 FILED—
Sep 22, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 20, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 18, 2020EX1GSOU EXTENSION 1 GRANTED—
Mar 18, 2020EXT1SOU EXTENSION 1 FILED—
Mar 18, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 12, 2019NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Sep 17, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 17, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 28, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Aug 13, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 13, 2019XAECEXAMINER'S AMENDMENT ENTERED—
Aug 13, 2019GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Aug 13, 2019GNEAEXAMINERS AMENDMENT E-MAILED—
Aug 13, 2019CNEAEXAMINERS AMENDMENT -WRITTEN—
Aug 10, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 10, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 9, 2019ALIEASSIGNED TO LIE—
Aug 1, 2019ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Apr 26, 2019GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Apr 26, 2019GNSLLETTER OF SUSPENSION E-MAILED—
Apr 26, 2019CNSLSUSPENSION LETTER WRITTEN—
Apr 25, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 24, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 24, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 9, 2018GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 9, 2018GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 9, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 8, 2018DOCKASSIGNED TO EXAMINER—
Jul 26, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 26, 2018NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance